Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures
Background: Chemoresistance is a major obstacle in high-grade serous carcinoma (HGSC) treatment. Although many patients initially respond to chemotherapy, the majority of them relapse due to Carboplatin and Paclitaxel resistance. Drug repurposing has surfaced as a potentially effective strategy that...
Saved in:
Main Authors: | Mariana Nunes, Sara Ricardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/1/14 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma
by: Kristina Mae Bienes, et al.
Published: (2025-01-01) -
Size distribution of extracellular vesicles in pretreatment ascites and plasma is correlated with primary treatment outcome in advanced high-grade serous carcinoma
by: Maruša Herzog, et al.
Published: (2025-02-01) -
Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation
by: Aline Talhouk, et al.
Published: (2025-01-01) -
Disease-free survival of 15 years after primary surgery in a patient with advanced high-grade serous ovarian cancer: a case report and literature review
by: Yaoqi Shi, et al.
Published: (2025-01-01) -
Cytopathologic Diagnosis of Serous Fluids /
by: Shidham, Vinod B
Published: (2007)